The growth of Viagra and its effect on the medicinal landscape presents a intricate question for shareholders. While the first sales figures were remarkable, the exclusivity has ended, leading to a deluge of copycat https://laylaropz461726.blogoscience.com/48106521/the-blue-pill-and-the-pharmaceutical-industry-a-dangerous-opportunity